Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aptamer, Argenx, Astellas, Atamyo, Beam, Cinfina, Esperion, Entera, Intrabio, Janssen, J&J, Medexus, Mesoblast, Synthekine, Takeda, Tiumbio, Verrica.